Oncology Central

The evolving field of intrahepatic cholangiocarcinoma

0

The study of intrahepatic cholangiocarcinoma (ICC) represents an exciting field with many evolving and potentially controversial topics, including increasing incidence, pathogenesis, improved diagnostic tools, new distinct staging systems, and emerging treatment algorithms. ICC is the second-most common primary hepatic malignancy after hepatocellular cancer (HCC) [1]. Worldwide, the ICC incidence varies widely, with, for example, an incidence of 0.3 per 100,000 people in Canada compared with 80 per 100,000 people in northeast Thailand [2]. Since formally defining ICC in the 1960s, growing evidence suggests the incidence is increasing globally, with some populations demonstrating incremental increases as high as 165% between the 1970s and 2000s [1,3].

To view restricted content, please:
Share:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.